Swedish Beverage Stock News

Beijer Alma AB announced that CEO Oscar Fredell, who only took up the role on November 3, 2025, stepped down for personal reasons on January 26, 2026, with board member Johnny Alvarsson appointed as acting President and CEO while a permanent successor is sought. The abrupt leadership change so soon after Fredell’s appointment raises questions about continuity in Beijer Alma’s executive agenda and medium-term organisational priorities. We will now examine how the abrupt departure of a...

Alfa Laval (OM:ALFA) is drawing fresh attention after announcing the official unveiling of its expanded La Porte Service Center, a Gulf Coast hub focused on large Welded Heat Exchanger servicing and sustainability. See our latest analysis for Alfa Laval. The La Porte expansion lands at a time when Alfa Laval’s share price has shown firm momentum, with a 10.46% 1 month share price return and a 16.22% 3 month share price return, while the 5 year total shareholder return of 131.56% reflects a...

Plejd AB (publ) recently reported its full-year 2025 results, with sales of SEK 1,073.32 million, revenue of SEK 1,083.03 million, and net income of SEK 180.24 million, all higher than the prior year. Basic earnings per share from continuing operations rose to SEK 16.12 from SEK 9.36, highlighting a marked improvement in profitability on a per-share basis. We will now examine how Plejd’s strong year-over-year earnings growth, particularly the jump in earnings per share, shapes its investment...

There's been a notable change in appetite for HEXPOL AB (publ) ( STO:HPOL B ) shares in the week since its full-year...

Skandinaviska Enskilda Banken AB has reported its fourth-quarter 2025 results, alongside proposing an ordinary dividend of SEK 8.50 per share and a special dividend of SEK 2.50 per share, following the January 29, 2026 announcements. Together with a SEK 1.25 billion share buyback program, these capital return plans highlight the bank’s current focus on distributing surplus capital to shareholders while maintaining a management buffer. We’ll now examine how this combination of higher cash...

Addnode Group AB (publ) ( STO:ANOD B ), is not the largest company out there, but it saw significant share price...

Sectra (OM:SECT B) is back in focus after Germany's TUM Klinikum Rechts der Isar expanded its enterprise imaging contract by adding pathology and ophthalmology modules under a five year agreement. See our latest analysis for Sectra. The TUM Klinikum contract comes at a time when Sectra's share price, now at SEK220.2, has faced pressure, with a 30 day share price return of an 8.1% decline and a 90 day share price return of a 25.8% decline. However, the 3 year total shareholder return of 40.2%...

Key Insights Institutions' substantial holdings in Lagercrantz Group implies that they have significant influence over...

Most readers would already be aware that FM Mattsson's (STO:FMM B) stock increased significantly by 13% over the past...

In late January 2026, Axfood AB reported full-year 2025 results showing higher sales of SEK 89,152 million and net income of SEK 2,339 million, alongside a proposed dividend increase to SEK 9.00 per share paid in two instalments and plans to open 10–15 new group-owned stores in 2026. An interesting angle for investors is how Axfood’s higher earnings per share and larger, split dividend coincide with a measured physical store expansion programme. Against this backdrop, we’ll look at how...

It's not a stretch to say that Paxman AB (publ)'s ( STO:PAX ) price-to-sales (or "P/S") ratio of 3.5x right now seems...

Paradox Interactive AB (publ) ( STO:PDX ) just released its latest annual report and things are not looking great...

Byggmax Group AB (publ)'s ( STO:BMAX ) dividend will be increasing from last year's payment of the same period to...

NOTE AB (publ)'s ( STO:NOTE ) recent earnings report didn't offer any surprises, with the shares unchanged over the...

The board of Midsona AB (publ) ( STO:MSON B ) has announced that it will be paying its dividend of SEK0.22 on the 13th...

With a median price-to-sales (or "P/S") ratio of close to 0.4x in the Auto industry in Sweden, you could be forgiven...

Gränges AB (publ) ( STO:GRNG ) will increase its dividend from last year's comparable payment on the 20th of May to...

H & M Hennes & Mauritz AB (publ) ( STO:HM B ) last week reported its latest annual results, which makes it a good time...

The board of Indutrade AB (publ) ( STO:INDT ) has announced that it will be paying its dividend of SEK3.10 on the 10th...

Addtech AB (publ.) ( STO:ADDT B ), is not the largest company out there, but it received a lot of attention from a...

Nordnet AB (publ) reported past fourth-quarter 2025 net income of SEK 774 million and full-year net income of SEK 3.02 billion, with basic earnings per share rising to SEK 11.83 from SEK 10.86 a year earlier. Alongside these results, the Board intends to propose a SEK 8.60 per share dividend for 2025, signalling confidence in the company’s earnings power and cash-generation capacity. With this combination of higher earnings and a proposed SEK 8.60 dividend, we’ll explore how Nordnet’s...

SSAB (OM:SSAB A) is back in focus after its latest full year report showed lower sales and net income, alongside a reduced proposed dividend, prompting investors to reassess the stock’s risk and income profile. See our latest analysis for SSAB. The annual report and reduced dividend proposal come after a mixed run in the share price, with a 19.99% 90 day share price return contrasting with a 44.26% 1 year total shareholder return. This suggests that recent momentum may be cooling after a...

Swedbank (OM:SWED A) has drawn fresh attention after its full year 2025 results, pairing a year over year decline in net income with a proposed ordinary and special dividend totaling SEK 29.80 per share. See our latest analysis for Swedbank. The dividend proposal and fresh earnings numbers arrive alongside a strong run in the shares, with the latest share price at SEK346.7 and a 30 day share price return of 6.55%. Over the past year, Swedbank has delivered a 56.88% total shareholder return...

Eisai recently asked European Union regulators to approve a monthly intravenous maintenance dosing regimen for Leqembi in early-stage Alzheimer’s patients, following an initial 18‑month period of biweekly infusions. This move aligns the EU treatment schedule with those in the US, UK and China, potentially improving treatment practicality and BioArctic’s royalty and milestone prospects under its partnership with Eisai. Next, we’ll examine how the push for a monthly Leqembi dosing regimen...